Oral oseltamivir treatment of influenza in children

Clicks: 430
ID: 270711
2001
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #19 of 46 articles by views in the pediatric infectious disease journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Oral oseltamivir administration is an efficacious and well-tolerated therapy for influenza in children when given within 48 h of onset of illness.
Reference Key
rj2001theoral Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Whitley RJ;Hayden FG;Reisinger KS;Young N;Dutkowski R;Ipe D;Mills RG;Ward P;;
Journal the pediatric infectious disease journal
Year 2001
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/11224828
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine safety treatment outcome research support non-u.s. gov't female male Child Infant preschool Clinical Trial Randomized Controlled Trial Double-Blind Method Multicenter Study time factors antiviral agents / administration & dosage antiviral agents / therapeutic use* oral human / complications influenza human / drug therapy* cough r j whitley acetamides / administration & dosage acetamides / therapeutic use* f g hayden oseltamivir pmid:11224828 doi:10.1097/00006454-200102000-00002 p ward human / physiopathology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.